Biotech consulting and expert advice | Labiotech https://www.labiotech.eu/expert-advice/ The European Biotech News Website Tue, 18 Apr 2023 10:53:30 +0000 en-US hourly 1 https://wordpress.org/?v=6.1.1 https://www.labiotech.eu/wp-content/uploads/2020/04/cropped-favicon-32x32.png Biotech consulting and expert advice | Labiotech https://www.labiotech.eu/expert-advice/ 32 32 Pharmacovigilance – how to deal with the data https://www.labiotech.eu/expert-advice/pharmacovigilance-dealing-with-data/ https://www.labiotech.eu/expert-advice/pharmacovigilance-dealing-with-data/#respond Tue, 18 Apr 2023 10:53:29 +0000 https://www.labiotech.eu/?p=116284 By Axel Hagel, practice leader, PV & RM services, IQVIA Life science data, especially safety data, is exploding. It is estimated that pharmaceutical data is increasing at a rate of 36% annually. This is more than other data-driven industries including finance (26% YoY) and manufacturing (30% YoY). This increase is in part due to digital […]

The post Pharmacovigilance – how to deal with the data appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/pharmacovigilance-dealing-with-data/feed/ 0
Nine tips to succeed in pharma-biotech partnerships https://www.labiotech.eu/expert-advice/biotech-partnerships-tips/ Mon, 20 Mar 2023 14:30:00 +0000 https://www.labiotech.eu/?p=59030 The question of whether to partner with another company is critical to the long-term development of a biotech. Nonetheless, it can be easy for a small company to underestimate the resources it needs to put into a successful collaboration. Here, we’ll go over some expert advice on what to do and what not to do […]

The post Nine tips to succeed in pharma-biotech partnerships appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
5 reasons why collaboration is important in research https://www.labiotech.eu/expert-advice/importance-of-research-collaboration/ https://www.labiotech.eu/expert-advice/importance-of-research-collaboration/#respond Tue, 14 Mar 2023 13:45:46 +0000 https://www.labiotech.eu/?p=114381 In the life sciences industry, collaboration is paramount in the field of research, to help move ideas and programs forward through the various stages. Here, experts explain the importance of research collaboration for biotechs. Collaboration in research is critical for the long-term success of biotechs, and going it alone is rarely a feasible option, particularly […]

The post 5 reasons why collaboration is important in research appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/importance-of-research-collaboration/feed/ 0
5 steps to strategic partnerships for healthtech startups https://www.labiotech.eu/expert-advice/5-steps-strategic-partnerships-healthtech-startups/ https://www.labiotech.eu/expert-advice/5-steps-strategic-partnerships-healthtech-startups/#respond Thu, 02 Mar 2023 11:41:48 +0000 https://www.labiotech.eu/?p=113837 By Varvara Melikhova, founder and CEO of Unison Innovations Strategic partnerships are a better way to build a product’s capabilities than outright acquisitions. While the M&A path is set out for the most mature successful startups, early-stage partnerships can enhance a product’s market value and provide access to Big Pharma expertise and infrastructure, which significantly […]

The post 5 steps to strategic partnerships for healthtech startups appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/5-steps-strategic-partnerships-healthtech-startups/feed/ 0
Five things you need to know about using CRISPR/Cas9 commercially https://www.labiotech.eu/expert-advice/five-things-crispr-cas9-license/ https://www.labiotech.eu/expert-advice/five-things-crispr-cas9-license/#respond Thu, 16 Feb 2023 11:23:42 +0000 https://www.labiotech.eu/?p=113224 By Michael Arciero, vice president of intellectual property and corporate development, ERS Genomics CRISPR/Cas9 gene editing technology is a patented invention, so any commercial use requires a license. Despite the confusion caused by several high-profile patent interference cases, the patent landscape for CRISPR/Cas9 is clearer than you may think. Here are the 5 key facts […]

The post Five things you need to know about using CRISPR/Cas9 commercially appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/five-things-crispr-cas9-license/feed/ 0
Chief Business Officers: Shedding Light on Biotech’s Dealmakers https://www.labiotech.eu/expert-advice/cbo-biotech-destiny-pharma/ https://www.labiotech.eu/expert-advice/cbo-biotech-destiny-pharma/#respond Mon, 02 May 2022 07:00:00 +0000 https://www.labiotech.eu/?p=101668 In addition to helping patients, biotech companies need to focus on the commercial potential of their work. Stephanie Bewick at Destiny Pharma outlines her experiences of how a Chief Business Officer maximizes their company’s commercial appeal and lands deals in the biotech industry.    Stephanie Bewick began her career as an academic researcher before spending more […]

The post Chief Business Officers: Shedding Light on Biotech’s Dealmakers appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/cbo-biotech-destiny-pharma/feed/ 0
How to Set up Manufacturing for Biotech Startups https://www.labiotech.eu/expert-advice/biotech-startups-manufacturing/ https://www.labiotech.eu/expert-advice/biotech-startups-manufacturing/#respond Mon, 21 Mar 2022 09:02:52 +0000 https://www.labiotech.eu/?p=101107 Deciding when and how to set up manufacturing can be essential to the success of any biotech startup. Experts share their advice on how to approach manufacturing decisions.  Great ideas for potential biotech products, often hatched in small startup settings, seem far removed from the complexities of manufacturing later down the line. Researchers and innovators […]

The post How to Set up Manufacturing for Biotech Startups appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/biotech-startups-manufacturing/feed/ 0
Transitioning from Academia to Chief Scientific Officer in the Biotech Industry https://www.labiotech.eu/expert-advice/chief-scientific-officer-biotech-industry/ https://www.labiotech.eu/expert-advice/chief-scientific-officer-biotech-industry/#respond Mon, 24 Jan 2022 06:30:56 +0000 https://www.labiotech.eu/?p=100509 Academics with a drive to turn their research into commercial products often end up in the position of Chief Scientific Officer at a biotech company. Kees Melief shares his own personal experience transitioning from academia to industry. After his retirement as an academic researcher at Leiden University, Cornelis ‘Kees’ Melief founded and became the Chief […]

The post Transitioning from Academia to Chief Scientific Officer in the Biotech Industry appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/chief-scientific-officer-biotech-industry/feed/ 0
“The Board of Directors Should Let the CEO Run the Company” https://www.labiotech.eu/expert-advice/alan-levy-ceo-board/ https://www.labiotech.eu/expert-advice/alan-levy-ceo-board/#respond Mon, 01 Nov 2021 07:00:32 +0000 https://www.labiotech.eu/?p=99565 The relationship between the board and the CEO can be essential to the success of a life sciences company. Drawing from his experience at both sides, Alan Levy shares his advice on how to make that relationship work.  Once known as the person who introduced portable defibrillators on the market in the 1990s, Alan Levy […]

The post “The Board of Directors Should Let the CEO Run the Company” appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/alan-levy-ceo-board/feed/ 0
How to Choose the Right Headquarters for Your Biotech Startup https://www.labiotech.eu/expert-advice/biotech-startup-headquarters/ https://www.labiotech.eu/expert-advice/biotech-startup-headquarters/#respond Tue, 05 Oct 2021 08:30:21 +0000 https://www.labiotech.eu/?p=99163 Choosing where to plant your biotech company’s roots is a fundamental question driven by access to capital, talent, and infrastructure. But the pandemic is accelerating a decentralization movement, changing the way companies think about headquarters. Regions like the Bay Area and Boston in the US, or the UK’s golden triangle remain huge draws for biotech […]

The post How to Choose the Right Headquarters for Your Biotech Startup appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/biotech-startup-headquarters/feed/ 0
What Makes a Good Chief Financial Officer in the Biotech Industry? https://www.labiotech.eu/expert-advice/chief-financial-officer-biotech-industry/ https://www.labiotech.eu/expert-advice/chief-financial-officer-biotech-industry/#respond Mon, 20 Sep 2021 09:54:35 +0000 https://www.labiotech.eu/?p=99001 A chief financial officer in the life sciences needs to develop their skills beyond technical expertise. Catherine Moukheibir shares her advice for CFOs in biotech drawing from her experience being one and hiring people for that position. Catherine Moukheibir’s career in biotech spans two decades. She has been a chief financial officer (CFO) twice, and […]

The post What Makes a Good Chief Financial Officer in the Biotech Industry? appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/chief-financial-officer-biotech-industry/feed/ 0
How to Pitch Your Biotech Startup to a Life Sciences Investor https://www.labiotech.eu/expert-advice/biotech-startup-pitch-investors/ https://www.labiotech.eu/expert-advice/biotech-startup-pitch-investors/#respond Wed, 18 Aug 2021 05:30:01 +0000 https://www.labiotech.eu/?p=98380 You’ve got the idea. You’ve got the science. You’ve got the team. Now all you need is the money, but that can be a tricky step for a new biotech entrepreneur. In any field, getting in front of the right investors is a challenge of its own. Once you’re pitching, experienced investors and entrepreneurs say […]

The post How to Pitch Your Biotech Startup to a Life Sciences Investor appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/biotech-startup-pitch-investors/feed/ 0
The Path to Becoming a Chief Medical Officer in the Biotech Industry https://www.labiotech.eu/expert-advice/chief-medical-officer-biotech-industry/ https://www.labiotech.eu/expert-advice/chief-medical-officer-biotech-industry/#respond Mon, 02 Aug 2021 06:00:38 +0000 https://www.labiotech.eu/?p=86700 Life science researchers with an entrepreneurship inclination are often attracted to leadership positions with a focus on medical science. Daniel Chung shares his journey to becoming the Chief Medical Officer of the biotech startup SparingVision.  Within a biotech company, a Chief Medical Officer (CMO) typically oversees and sets the company’s strategy and direction regarding the […]

The post The Path to Becoming a Chief Medical Officer in the Biotech Industry appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/chief-medical-officer-biotech-industry/feed/ 0
How to Protect Your Intellectual Property as a Biotech Startup https://www.labiotech.eu/expert-advice/intellectual-property-biotech-startup/ https://www.labiotech.eu/expert-advice/intellectual-property-biotech-startup/#respond Mon, 19 Jul 2021 06:00:35 +0000 https://www.labiotech.eu/?p=86590 Biotechs always start with great scientific ideas, but if you can’t protect them, you can’t see them through to execution. Companies need to start developing long-term intellectual property strategies almost as early as they are devising the ideas that need protecting. Experts say that the right intellectual property (IP) strategy for a new biotech depends […]

The post How to Protect Your Intellectual Property as a Biotech Startup appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/intellectual-property-biotech-startup/feed/ 0
Why the Right Team is Key for Biotech Success https://www.labiotech.eu/expert-advice/biotechnology-management-team/ https://www.labiotech.eu/expert-advice/biotechnology-management-team/#respond Mon, 05 Jul 2021 08:30:00 +0000 https://www.labiotech.eu/?p=61645 For any startup, and especially for biotechnology startups, success depends on three main factors: science, financing, and people. One of the key factors investors look for is having a management team that can raise money and make good use of it to advance the science of the company. According to Sinclair Dunlop, Managing Partner at […]

The post Why the Right Team is Key for Biotech Success appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/biotechnology-management-team/feed/ 0
What Makes a Biotech Executive Stand Out? https://www.labiotech.eu/expert-advice/biotech-executive/ https://www.labiotech.eu/expert-advice/biotech-executive/#respond Wed, 16 Jun 2021 06:00:15 +0000 https://www.labiotech.eu/?p=86139 Talented executives are always in demand in the biotech industry. Leaders who stand out in the field demonstrate flexibility to deal with change and failure, as well as a track record of hitting milestones. Successful biotechs typically progress along similar paths, moving from small scientist-driven enterprises eager to test their ideas, to established companies with […]

The post What Makes a Biotech Executive Stand Out? appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/biotech-executive/feed/ 0
How to Spend Your Biotech Startup’s Money https://www.labiotech.eu/expert-advice/spend-biotech-startup-money/ https://www.labiotech.eu/expert-advice/spend-biotech-startup-money/#respond Mon, 17 May 2021 05:00:33 +0000 https://www.labiotech.eu/?p=85736 Biotech investment rounds tend to draw big headlines, but experienced players know the real work is done in between them. Avoiding some common pitfalls can make the difference between petering out and pressing on. Managing a biotech startup means always keeping an eye towards the next financing round. But piquing the next investor’s interest requires […]

The post How to Spend Your Biotech Startup’s Money appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/spend-biotech-startup-money/feed/ 0
How to Build a Successful Company Culture in Biotech https://www.labiotech.eu/expert-advice/biotech-company-culture/ https://www.labiotech.eu/expert-advice/biotech-company-culture/#respond Wed, 28 Apr 2021 05:00:45 +0000 https://www.labiotech.eu/?p=85623 Company culture can be essential to the success of a biotech company. Sabine Dandiguian, Managing Partner at the life sciences VC firm Jeito Capital, shares her experience building a thriving company culture in the life sciences. Company culture is “something very special” that borders on collective intelligence, says Sabine Dandiguian. There are some basics to […]

The post How to Build a Successful Company Culture in Biotech appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/biotech-company-culture/feed/ 0
How to Negotiate a Successful Research Collaboration Agreement https://www.labiotech.eu/expert-advice/negotiate-research-collaboration-agreement/ https://www.labiotech.eu/expert-advice/negotiate-research-collaboration-agreement/#respond Wed, 24 Mar 2021 06:00:08 +0000 https://www.labiotech.eu/?p=85083 Negotiating the terms of a research collaboration can be a minefield. Life sciences attorney Lori Waldron shares her extensive experience helping biotech and pharma companies negotiate agreements. Amid a dramatic increase in funding research and development in the medical biotech sector, both larger pharmaceutical companies looking to diversify their portfolios and startups looking for a […]

The post How to Negotiate a Successful Research Collaboration Agreement appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/expert-advice/negotiate-research-collaboration-agreement/feed/ 0
How Much Control Should Investors Have Over Your Biotech Company? https://www.labiotech.eu/expert-advice/investor-control-biotech-company/ Wed, 13 Jan 2021 10:00:30 +0000 https://www.labiotech.eu/?p=81369 While getting funding from a star investor can be great for business, many biotech entrepreneurs dread the possibility of investors taking control in a situation that eerily resembles a hostile takeover. But it needn’t be that way at all. Biotech founders often complain that investors, especially VCs, demand too much control over company operations. This […]

The post How Much Control Should Investors Have Over Your Biotech Company? appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>